Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Activity in Vivo
14%
Angiogenesis
28%
Angiogenic Activity
14%
Binding Effect
14%
Binding Specificity
14%
Biodistribution Studies
14%
Cancer Biology
14%
Cancer Cell Lines
14%
Cell Invasion
14%
Cell Proliferation
14%
Cellular Uptake
14%
Cellular Viability
14%
Compound Injection
14%
Endothelial Cells
14%
Fluorescent Dye
28%
Growth Factors
14%
Human Endothelial Cells
14%
Human Umbilical Vein Endothelial Cells (HUVECs)
28%
Imaging Agents
14%
In Vitro Study
14%
Kidney
14%
Linker
14%
Liver
14%
Matrigel Plug Assay
14%
MDA-MB-231
14%
Orally Bioavailable
14%
Pericyte Coverage
14%
Pseudotumor
14%
Small Molecule Tyrosine Kinase Inhibitors
14%
Specific Binding
100%
Spleen
14%
Therapeutic Effect
14%
Tumor
14%
Tumor Angiogenesis
14%
Tumor Growth
14%
Tumor Vessels
14%
U87MG
14%
Vandetanib
100%
Vascular Endothelial Growth Factor
14%
Vascular Endothelial Growth Factor Receptor (VEGFR)
14%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
100%
Vascular Sprouting
14%
Vessel Development
14%
Vessel Stability
14%
Weak Effect
14%
Xenograft Tumor Model
14%
ZD6474
100%
Medicine and Dentistry
Angiogenesis
22%
Biodistribution
11%
Cancer Cell Line
11%
Cancer Pathobiology
11%
Cell Invasion
11%
Cell Proliferation
11%
Cell Viability
11%
Dimer
100%
Endothelial Cell
22%
Fluorescent Dye
22%
Growth Factor
11%
Imaging Agent
11%
In Vitro
33%
Matrigel
11%
Monomer
100%
Neoplasm
22%
Pericyte
11%
Pseudotumor
11%
Sprout
11%
Therapy Effect
11%
Tumor Angiogenesis
11%
Tumor Model
11%
Tumor Progression
11%
Tyrosine-Kinase Inhibitor
11%
Vandetanib
100%
Vasculotropin
11%
Vasculotropin Receptor 2
100%
Xenograft
11%
Pharmacology, Toxicology and Pharmaceutical Science
Biodistribution
11%
Dimer
100%
Fluorescent Dye
22%
Growth Factor
11%
Malignant Neoplasm
22%
Matrigel
11%
Monomer
100%
Neoplasm
33%
Protein Tyrosine Kinase Inhibitor
11%
Pseudotumor
11%
Therapeutic Effect
11%
Tumor Growth
11%
Tumor Model
11%
Vandetanib
100%
Vasculotropin
11%
Vasculotropin Receptor 2
100%